Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change
23/07/26	€0.1512	-1.82%
22/07/26	€0.1540	+2.53%
21/07/26	€0.1502	0.00%
20/07/26	€0.1502	-8.08%
17/07/26	€0.1634	-2.85%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Delayed Deutsche Boerse AG Other stock markets 07:01:44 23/07/2026 BST			5-day change	1st Jan Change
0.1512 ^EUR	-1.82%		-10.11%	-26.06%

07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI

Market Cap	49.49M 56.48M 45.94M 42.22M 79.55M 5.45B 80.72M 547M 214M 2.67B 212M 207M 9.21B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	49.61M 56.62M 46.06M 42.32M 79.75M 5.46B 80.92M 549M 215M 2.67B 213M 208M 9.24B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
18/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI

07-15	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
07-15	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

Klea Holding Share Price Deutsche Boerse AG

Stocks

7V91

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

07-20	Klea Holding : Déclaration des transactions sur actions propres
07-15	Klea Holding vise une amélioration de sa rentabilité au second semestre
07-15	Klea Holding : Smart Salem enregistre un puissant rebond de son activité en juin 2026, confirme sa solide rentabilité et ses perspectives favorables
07-13	Klea Holding : Déclaration des transactions sur actions propres
07-06	Klea Holding : Déclaration des transactions sur actions propres

1 day	-1.82%
1 week	-10.11%
Current month	-10.53%
1 month	-13.60%
3 months	-14.58%
6 months	-29.01%
Current year	-26.06%

1 week	0.15	0.17
1 month	0.15	0.18
Current year	0.15	0.24
1 year	0.15	0.3
3 years	0.14	0.49
5 years	0.07	0.58
10 years	0	14.84

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-1.82%	-10.11%	-	-	56.48M
CVS HEALTH CORPORATION	-0.80%	+0.31%	+72.73%	+40.66%	138B
HCA HEALTHCARE, INC.	+0.91%	-2.73%	+6.21%	+31.57%	82.5B
FRESENIUS SE & CO. KGAA	-1.66%	+2.46%	+2.32%	+53.07%	28.01B
QUEST DIAGNOSTICS INCORPORATED	+7.37%	+8.99%	+33.88%	+58.47%	23.23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.32%	+1.27%	-14.30%	-29.20%	19.79B
TENET HEALTHCARE CORPORATION	-0.76%	-2.62%	+22.54%	+152.30%	16.83B
DAVITA INC.	+0.48%	-0.14%	+54.43%	+128.88%	14.9B
REDE D'OR SÃO LUIZ S.A.	-1.88%	-5.66%	+2.24%	-5.76%	14.98B
FRESENIUS MEDICAL CARE AG	+0.47%	+2.26%	-6.42%	-11.50%	12.96B
Average	+0.36%	+0.83%	+19.29%	+46.50%	39.01B
Weighted average by Cap.	+0.24%	+0.94%	+34.90%	+41.95%

	2024	2025
Net sales	17.26M 19.7M 16.02M 14.72M 27.75M 1.9B 28.15M 191M 74.71M 930M 73.95M 72.35M 3.21B	22.17M 25.3M 20.58M 18.91M 35.63M 2.44B 36.16M 245M 95.95M 1.19B 94.97M 92.92M 4.13B
Net income	1.4M 1.6M 1.3M 1.2M 2.26M 155M 2.29M 15.54M 6.08M 75.71M 6.02M 5.89M 262M	2.28M 2.6M 2.12M 1.95M 3.67M 251M 3.72M 25.23M 9.87M 123M 9.77M 9.56M 425M
Net Debt	2.58M 2.94M 2.39M 2.2M 4.14M 284M 4.2M 28.48M 11.15M 139M 11.03M 10.79M 479M	125K 143K 116K 107K 201K 13.77M 204K 1.38M 541K 6.74M 536K 524K 23.27M